0.72751.70% ( -0.0126 )
Closed: Oct 9, 16:00:00 (EDT)Q2 FY2026 EarningsQ2 FY26 results missed consensus on the top and operating lines, with revenue of $2.18M (-9.2% vs. consensus) and gross margin of 35.1% (-6.9pct vs. consensus). Despite the operating miss, the bottom line reported a GAAP net income of $0.89M, significantly beating the expected loss of $1.43M, driven primarily by a $2.45M one-time non-cash gain from the remeasurement of the Alabama JV acquisition. Management secured a critical $15M-$50M equity financing facility (AMPA) post-quarter to address persistent going concern risks and fund a robust acquisition pipeline.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: INVO Fertility(IVF) the Revenue is 2.175 M (+16.73%), Miss estimate;the EBIT is -1.29 M (+56.87%), Miss estimate;the EPS is 0.35 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B16.73%
0.00B28.56%
-0.00B11.83%
EBITMiss expectations
-0.00B56.87%
-0.00B58.96%
-0.00B2.09%
EPSExceed expectations
0.35--
-5.6--
+5.9500--%
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
